Solara Active Pharma Sciences Ltd. Financials: Quarterly Results
Revenue
391.98
Cr.
PAT
9.60
Cr.
EBITDA
36.31
Cr.
Solara Active Pharma Sciences Ltd. Q4FY26 Financial Metrics
| Indicator | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 387.29 | 349 | 313.54 | 319.15 | 273.01 |
| Total Income From Operations (Cr.) | 387.29 | 349 | 313.54 | 319.15 | 273.01 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 36.31 | 11.77 | 10.73 | 34.42 | 27.02 |
| P/L Before Exceptional Items & Tax (Cr.) | 8.74 | -10.68 | -10.10 | 10.52 | -2.10 |
| P/L After Tax from Ordinary Activities (Cr.) | 9.60 | -17.43 | -10.10 | 10.52 | -2.10 |
| Net Profit/Loss For the Period (Cr.) | 9.60 | -17.43 | -10.10 | 10.52 | -2.10 |
| Basic EPS | 2.20 | -3.98 | -2.36 | 2.46 | -0.93 |
FAQs
Solara Active Pharma Sciences Ltd. announced its quarterly results for Q4 FY2026 on May 15, 2026.
In Q4 FY2026, Solara Active Pharma Sciences Ltd. are as follows:
Revenue: ₹391.98 crore
Net Profit: ₹9.60 crore.
For Q4 FY2026, Solara Active Pharma Sciences Ltd. posted ₹391.98 crore in revenue and ₹9.60 crore in net profit.
Past quarterly results for Solara Active Pharma Sciences Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.